Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gemfibrozil

"Gemfibrozil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. These decreases occur primarily in the VLDL fraction and less frequently in the LDL fraction. Gemfibrozil increases HDL subfractions HDL2 and HDL3 as well as apolipoproteins A-I and A-II. Its mechanism of action has not been definitely established.


This graph shows the total number of publications written about "Gemfibrozil" by people in Harvard Catalyst Profiles by year, and whether "Gemfibrozil" was a major or minor topic of these publication.
Bar chart showing 32 publications over 23 distinct years, with a maximum of 3 publications in 2000 and 2004
To see the data from this visualization as text, click here.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.